Healthtech Investors & VC Firms in North America

2659 firms in this list, with a median first check of $500K. 645 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AC ACVC Partners EJHLJLMC6 people	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
AL Alerion Ventures LRWBAB3 people · Follows rounds	88🔒	Charleston	US	Seed–Growth	—	+ Add to CRM
FL Flight Ventures SMZFNCBJ12 people · Follows rounds	88🔒	San Francisco	US	—	—	+ Add to CRM
OC OCV Partners RRALCBHZ6 people · Leads rounds	88🔒	Los Angeles	US	Seed–Series C	—	+ Add to CRM
RE Real Tech Capital BCEHDGDB5 people	88🔒	Chicago	US	Pre-Seed–Series A	—	+ Add to CRM
VI Vital Venture Capital ACNCNLCA5 people · Leads rounds	88🔒	Washington	US	Series A–Growth	$1M – $3M	+ Add to CRM
FI Figure 8 Investments DAKC2 people · Follows rounds	88🔒	Western North Carolina	US	Seed–Series B	$50K – $500K	+ Add to CRM
FI First Ascent Ventures RBTVJDKO7 people · Leads rounds	88🔒	Toronto	CA	Series A–Late Stage	$3.6M – $7.3M	+ Add to CRM
NO North South Ventures ALDNITPK4 people	88🔒	Toronto	CA	Pre-Seed–Seed	—	+ Add to CRM
AC Access Biotechnology DBLRCB3 people · Leads rounds	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
BD BDC Seed Venture Fund DAMSAADN9 people · Leads rounds	88🔒	Montréal	CA	Seed	—	+ Add to CRM
NU NuVentures	88🔒	New Jersey	US	Seed–Growth	—	+ Add to CRM
RE Render Capital PHTNRB3 people · Leads rounds	88🔒	Clarksville	US	Pre-Seed–Series A	$750K – $1.3M	+ Add to CRM
BO Bonaventure Equity, LLC ROJDBK11 people	88🔒	Raleigh	US	Seed–Series A	—	+ Add to CRM
CA Cancer Fund ALABJRYZ11 people	88🔒	Phoenix	US	Seed–Series A	—	+ Add to CRM
ME MESA VERDE VENTURE PARTNERS CNFMDMRB8 people	88🔒	La Jolla	US	Seed–Series A	—	+ Add to CRM
NA Narya Capital CGFDWSJV5 people · Follows rounds	88🔒	Columbus	US	Pre-Seed–Series A	—	+ Add to CRM
SO Socium Ventures ADDYNCTH5 people	88🔒	Atlanta	US	Seed–Growth	$3M – $25M	+ Add to CRM
TO Topmark Partners TMSLBSDF5 people · Leads rounds	88🔒	Tampa	US	Seed–Late Stage	$2M – $5M	+ Add to CRM
AV Avego BioScience Capital ARBV2 people · Leads rounds	88🔒	Alpharetta	US	Series A–Late Stage	—	+ Add to CRM
CA Cambrian Ventures RSAJ2 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Seed	$300K – $1M	+ Add to CRM
HE Headwater Ventures MM1 person · Follows rounds	88🔒	Minneapolis	US	Pre-Seed–Seed	—	+ Add to CRM
BO BOLD Longevity PHSYTBAA10 people · Follows rounds	88🔒	Boston	US	Growth	—	+ Add to CRM
M M ACCELERATOR AMACAPEY10 people · Follows rounds	88🔒	Los Angeles	US	Pre-Seed–Seed	$1M – $5M	+ Add to CRM

ACVC Partners

Silicon ValleyPre-Seed–Series A

EJHLJLMC6 people

Alerion Ventures

CharlestonSeed–Growth

LRWBAB3 people

Flight Ventures

San Francisco

SMZFNCBJ12 people

OCV Partners

Los AngelesSeed–Series C

RRALCBHZ6 people

Real Tech Capital

ChicagoPre-Seed–Series A

BCEHDGDB5 people

Vital Venture Capital

WashingtonSeries A–Growth$1M – $3M

ACNCNLCA5 people

Figure 8 Investments

Western North CarolinaSeed–Series B$50K – $500K

DAKC2 people

First Ascent Ventures

TorontoSeries A–Late Stage$3.6M – $7.3M

RBTVJDKO7 people

North South Ventures

TorontoPre-Seed–Seed

ALDNITPK4 people

Access Biotechnology

New YorkSeed–Late Stage

DBLRCB3 people

BDC Seed Venture Fund

MontréalSeed

DAMSAADN9 people

NuVentures

New JerseySeed–Growth

Render Capital

ClarksvillePre-Seed–Series A$750K – $1.3M

PHTNRB3 people

Bonaventure Equity, LLC

RaleighSeed–Series A

ROJDBK11 people

Cancer Fund

PhoenixSeed–Series A

ALABJRYZ11 people

MESA VERDE VENTURE PARTNERS

La JollaSeed–Series A

CNFMDMRB8 people

Narya Capital

ColumbusPre-Seed–Series A

CGFDWSJV5 people

Socium Ventures

AtlantaSeed–Growth$3M – $25M

ADDYNCTH5 people

Topmark Partners

TampaSeed–Late Stage$2M – $5M

TMSLBSDF5 people

Avego BioScience Capital

AlpharettaSeries A–Late Stage

ARBV2 people

Cambrian Ventures

San FranciscoPre-Seed–Seed$300K – $1M

RSAJ2 people

Headwater Ventures

MinneapolisPre-Seed–Seed

MM1 person

BOLD Longevity

BostonGrowth

PHSYTBAA10 people

M ACCELERATOR

Los AngelesPre-Seed–Seed$1M – $5M

AMACAPEY10 people

Data sourced from public filings and firms' own websites — see our methodology.